Arterial Bypass Surgery: When a Vein Graft or a Synthetic Graft Is Needed

If you have been told that your leg arteries are severely blocked and that angioplasty may no longer be enough, the words arterial bypass surgery can feel alarming. They should not. Arterial bypass surgery is a proven, well-established operation that has saved thousands of limbs worldwide. Understanding what arterial bypass surgery involves, when it is needed, and which type of graft is right for you puts you firmly in control of the conversation with your surgeon.

What Is Arterial Bypass Surgery?

Arterial bypass surgery is an open surgical procedure in which a surgeon creates a new pathway for blood to travel around a blocked or severely narrowed artery. A conduit, either a vein taken from elsewhere in the patient's own body or a synthetic tube, is attached above and below the blockage so that blood bypasses the diseased segment and reaches the tissues downstream.

The operation is most commonly performed on the arteries of the leg when peripheral arterial disease has progressed to a point where blood flow is critically reduced. It is one of the oldest and most durable interventions in vascular surgery, with outcomes data extending back several decades.

When Arterial Bypass Is Needed

Not every blocked artery requires bypass surgery. The decision is reached when less invasive options have been exhausted or are anatomically unsuitable.

Severe Peripheral Arterial Disease and Critical Limb Ischaemia

Peripheral arterial disease (PAD) begins with fatty plaque accumulating inside the arteries that supply the legs. In its earlier stages, walking becomes painful, a symptom known as intermittent claudication. As disease progresses, blood flow can fall to the point where tissues are starved of oxygen even at rest. This is critical limb ischaemia, the most severe stage of PAD, and it represents a genuine threat to the limb.

The Society for Vascular Surgery (SVS) recognises critical limb ischaemia as a condition requiring urgent revascularisation to prevent amputation. Patients present with rest pain, typically a burning sensation in the foot at night, or with non-healing ulcers and gangrene. In Dubai, many of these patients also carry a diagnosis of diabetic foot, where nerve damage masks pain until ulceration is already advanced. The UAE's diabetes burden means vascular surgeons here see this combination more often, and earlier intervention is almost always better.

When Angioplasty or Stenting Is Not Enough

Peripheral angioplasty and stenting remain the first-line revascularisation strategies for most patients with PAD. These catheter-based techniques widen the artery from the inside using a balloon, with or without a metal stent, and they carry shorter recovery times than open surgery.

There are circumstances, however, where angioplasty cannot deliver durable results. Long-segment blockages that extend over many centimetres of artery, heavily calcified lesions that resist balloon dilation, arteries that are completely occluded from the groin down to the knee or below, and cases where a previous angioplasty has failed are all situations where bypass surgery becomes the more reliable answer. According to NHS guidance on PAD treatment, bypass surgery is generally considered longer-lasting than angioplasty and may need to be repeated less often. The choice between them is made by a specialist multidisciplinary team weighing anatomy, comorbidities, and the patient's fitness for general or regional anaesthesia.

Vein Graft vs Synthetic Graft

The choice of conduit is one of the most consequential technical decisions in arterial bypass surgery. Two broad categories exist: the patient's own (autologous) vein, most often the great saphenous vein running along the inner thigh and calf, and synthetic prosthetic grafts made from polytetrafluoroethylene (PTFE) or Dacron.

Both have their place. The decision depends on the location of the bypass, the length of the segment being bypassed, and whether the patient has a usable vein available.

• Criterion | Autologous Vein Graft (e.g. Great Saphenous Vein) | Synthetic / Prosthetic Graft (PTFE / Dacron)

• Material, Patient's own saphenous or arm vein | Man-made polymer tube (PTFE or Dacron)

• Best used for, Below-knee bypasses; tibial and popliteal arteries | Above-knee femoropopliteal or aortoiliac bypasses

• Long-term patency, Superior, especially below the knee | Good above the knee; lower below the knee

• Infection risk, Very low (biological material) | Low but higher than autologous vein; infection can be severe

• Availability, Requires suitable vein; previous surgery or varicosity may limit use | Always available; no harvest needed

  
  

The vein graft is the preferred conduit for bypasses below the knee. Smaller arteries distal to the knee have lower blood flow and higher resistance, and synthetic materials do not perform as well in these vessels over time. When the bypass must reach the tibial arteries or the foot, using the patient's own vein significantly improves the chance of the graft remaining open years later.

Synthetic grafts come into their own when no suitable vein is available, or when the bypass is confined to the larger, higher-flow vessels above the knee such as the femoral or iliac arteries. PTFE grafts in the above-knee position carry patency rates that are broadly comparable to vein in medium-term follow-up, making them a reasonable alternative.

How the Procedure Works

Thorough assessment precedes the operation. Duplex ultrasound maps the arteries and identifies usable vein. CT angiography or MR angiography provides a road map of the entire arterial tree from the aorta to the foot, showing where blockages begin and end and which artery can serve as the outflow below the graft.

In the operating theatre, the patient receives either general anaesthesia or a regional spinal or epidural block, depending on their cardiac and pulmonary fitness. Where a vein graft is planned, the saphenous vein is harvested from the thigh or lower leg through one or more incisions. The surgeon then exposes the artery above the blockage (the inflow vessel) and the artery below (the outflow vessel), and sews the graft to each with fine stitches. These joins are called anastomoses. The graft is then routed through a natural tissue tunnel between the two anastomosis sites.

Once the clamps are released, blood flows through the new conduit and reaches the ischaemic tissue. The surgeon confirms this with intraoperative duplex ultrasound or angiography before closing. The whole procedure typically takes two to four hours, longer for complex multi-level disease.

Risks and Recovery

Arterial bypass surgery is a major operation and carries real risks. NHS clinical guidance notes that both bypass surgery and angioplasty carry a small risk of serious complications including heart attack, stroke, and death. The decision to proceed is always a careful balance of surgical risk against the risk of losing the limb without intervention.

Other risks include wound infection, particularly at the vein harvest sites, graft thrombosis in the early postoperative period, lymphatic leakage in the groin, and nerve injury causing temporary numbness. Patients with diabetes face a higher infection risk at all wound sites and require close perioperative blood glucose management.

Hospital stay is typically five to seven days for an uncomplicated lower limb bypass, though this varies. Walking begins within a day or two of the operation. Full recovery to independent activity takes four to six weeks.

Graft surveillance matters greatly after discharge. Duplex ultrasound scans at one month, three months, six months, and annually allow the vascular team to detect any graft narrowing before it causes a complete occlusion. Grafts that narrow can often be saved by a short balloon angioplasty at the anastomosis site if caught early.

Lifelong antiplatelet medication, usually aspirin or clopidogrel, reduces the risk of graft clotting and also reduces the patient's broader cardiovascular risk. Statin therapy, blood pressure control, and smoking cessation are not optional extras. Smoking is among the most powerful accelerators of arterial disease, and patients who continue to smoke after bypass surgery face a substantially higher rate of graft failure and major amputation.

The Role of a Vascular Surgeon and Multidisciplinary Care

Arterial bypass surgery for limb salvage is not a procedure that can be performed well in isolation. The patients who need it most are often the most complex: diabetic, with renal impairment, cardiac disease, and infected foot ulcers that require simultaneous surgical debridement. A vascular surgeon is the central figure, but the team around them determines the outcome.

The approach to critical limb ischaemia involves diabetologists managing perioperative blood glucose, podiatry assessing and offloading the foot, wound care nurses managing dressings, physiotherapists supervising early mobilisation, and an intensive care team available if needed. This kind of infrastructure cannot be replicated in a standalone outpatient clinic. Limb salvage operations require a hospital with functioning theatres, intensive care backup, interventional radiology capability, and a vascular ward familiar with post-bypass monitoring protocols.

A patient in Dubai presenting with a gangrenous toe and a blocked superficial femoral artery needs all of those things running in parallel on the same day. The Society for Vascular Surgery (SVS) describes surgical bypass as one of the definitive treatments for advanced PAD, and the evidence base for its use in diabetic patients with critical limb ischaemia is extensive.

When to See a Specialist in Dubai

Rest pain that wakes you at night, a foot wound that has not healed in two weeks despite dressings, a cold or pale foot, or a sudden change in the colour of your toes are all signs that warrant urgent vascular assessment, not a wait-and-see approach. In Dubai's diabetic population, nerve damage means pain is often absent even when tissue damage is advanced. By the time a patient notices discolouration, the window for limb salvage may already be narrow.

Dr. Soroush Sohrabi is a UK-trained Consultant Vascular and Endovascular Surgeon (FRCS, CCT) practising at NMC Royal Hospital, Dubai, with a Cleveland Clinic Advanced Endovascular Fellowship and 77 peer-reviewed publications.

If you are concerned about the blood supply to your legs or feet, book a consultation early. Early assessment is almost always associated with more treatment options and better outcomes.

Why Choose Dr. Soroush Sohrabi for Arterial Disease in Dubai

When choosing a vascular surgeon in Dubai for complex arterial disease or limb salvage work, patients should look for specific, verifiable qualifications: dedicated training in vascular surgery rather than general surgery, a fellowship examination, access to the full spectrum of both endovascular and open surgical techniques, and practice at a hospital with the infrastructure to manage high-risk patients. Dr. Soroush Sohrabi meets every one of those criteria.

Dr. Sohrabi holds the FRCS in Vascular Surgery from the Royal College of Surgeons of England, one of the most rigorous vascular surgery specialist qualifications in the world. He completed an advanced endovascular fellowship at the Cleveland Clinic in the United States, and his 77 peer-reviewed publications with over 1,183 academic citations reflect a depth of research engagement that is rare in a purely clinical practice. He previously served as Clinical Director of Vascular Surgery Services in North Wales, leading a team of 10 consultants across three hospitals serving over 700,000 patients.

Critically for patients facing bypass surgery, the procedure cannot be safely performed without full hospital infrastructure. Dr. Sohrabi operates at NMC Royal Hospital, Dubai, a facility with dedicated vascular theatres, interventional radiology, intensive care, and a ward team experienced in post-bypass monitoring. This is not a standalone clinic. It is a full-service hospital environment where a patient who develops an intraoperative complication or requires overnight high-dependency monitoring is already in the right place.

The NHS, AHA, and SVS all affirm that complex revascularisation for critical limb ischaemia should be performed by specialist vascular surgeons within multidisciplinary teams. Dr. Sohrabi's service is built precisely on that model. Patients who have previously been told their case is too complex for catheter-based treatment, or who have experienced a failed angioplasty, are encouraged to seek a specialist opinion before accepting amputation as an inevitability.

Frequently Asked Questions

How long does arterial bypass surgery take?

The operation typically takes two to four hours depending on the complexity of the arterial anatomy and the length of the bypass. Multi-level disease requiring more than one bypass segment, or cases where the outflow artery is small and deep in the calf, will take longer. The anaesthetic team manages the patient continuously throughout, and the procedure is conducted in a fully equipped vascular operating theatre.

Will I need to stay in hospital after arterial bypass?

Most patients remain in hospital for five to seven days after an uncomplicated lower limb bypass. Patients with significant cardiac, renal, or infective complications may need longer. Mobilisation begins within 24 to 48 hours of surgery under physiotherapy supervision, and discharge planning starts early to ensure a safe home environment and community nursing support where needed.

Is my own vein always used, or can a synthetic graft be used instead?

This depends on the location of the bypass and whether a suitable vein is available. The great saphenous vein is preferred for bypasses that must reach the arteries below the knee, because vein grafts achieve significantly better long-term patency in these smaller, lower-flow vessels. Synthetic PTFE or Dacron grafts are used when no suitable vein is available or when the bypass is confined to the larger arteries above the knee, where their patency rates are broadly comparable to vein in medium-term follow-up.

What happens if the bypass graft blocks?

Graft occlusion can occur early (within the first month), usually related to a technical problem at the anastomosis or poor outflow, or late, usually related to progressive disease or intimal hyperplasia narrowing the graft over time. Regular duplex ultrasound surveillance identifies narrowing before complete occlusion occurs, allowing a corrective procedure. If the graft does block, options include catheter-directed thrombolysis, surgical thrombectomy, or revision bypass depending on how long ago the occlusion occurred.

Can arterial bypass surgery be performed if I have diabetes?

Yes. Patients with diabetes are among the most frequent candidates for bypass surgery, particularly those with critical limb ischaemia and non-healing foot ulcers. Careful perioperative blood glucose management, combined with a multidisciplinary team including diabetologists, podiatry, and wound care nurses, allows bypass surgery to be performed safely. The UAE's high diabetes prevalence means vascular teams here have extensive experience managing this patient group.

How soon can I return to normal activities after arterial bypass?

Most patients are walking independently within a week of discharge and return to light daily activity within four to six weeks. More physically demanding work or exercise may take eight to twelve weeks. Driving is not recommended until the groin or leg wound is fully healed and the patient can perform an emergency stop without pain. The vascular team advises on activity timelines individually based on wound healing and graft surveillance results.

Key Takeaways

• Arterial bypass surgery is a proven open surgical procedure that creates a new blood flow pathway around a blocked artery, most commonly used for severe peripheral arterial disease when catheter-based options are unsuitable or have failed, according to NHS guidance.

• The Society for Vascular Surgery (SVS) lists surgical bypass as one of the definitive treatments for advanced PAD, alongside angioplasty, stenting, and atherectomy, with the choice of technique determined by the anatomical extent and location of disease.

• Autologous vein grafts, particularly from the great saphenous vein, are the preferred conduit for below-knee bypasses because they achieve superior long-term patency compared to synthetic PTFE or Dacron grafts in small-calibre, lower-flow vessels.

• According to NHS guidance, the results of arterial bypass surgery are generally considered longer-lasting than angioplasty, meaning the procedure is less likely to require repetition, though both techniques carry comparable risks of serious complications.

• Graft surveillance with duplex ultrasound at regular intervals after surgery allows the vascular team to detect developing graft stenosis before complete occlusion occurs, significantly improving long-term patency rates.

• Dr. Soroush Sohrabi at NMC Royal Hospital Dubai offers the full range of arterial revascularisation treatments, from endovascular angioplasty and stenting to open bypass surgery for complex multi-level disease, within a hospital with dedicated vascular theatres, interventional radiology, and intensive care capability.

• 
  

About the Author

Dr. Soroush Sohrabi MD, PhD, FRCS, CCT is a Consultant Vascular and Endovascular Surgeon at NMC Royal Hospital, Dubai. He trained in the United Kingdom, holds the FRCS in Vascular Surgery and a CCT, completed an advanced endovascular fellowship at the Cleveland Clinic, USA, and has published 77 peer-reviewed papers with over 1,183 academic citations. He is licensed by the UK GMC (No. 5207627) and the Dubai Health Authority (No. 48905551).

Medically reviewed by Dr. Soroush Sohrabi MD, PhD, FRCS, CCT, Consultant Vascular Surgeon, June 2026.